Researchers have introduced a new treatment option for high blood pressure, known as ultrasound renal denervation (uRDN). This innovative therapy, delivered through the Paradise™ system, uses ultrasound energy to calm overactive nerves around the renal arteries, which can contribute to hypertension. This method is particularly significant for the one-third of people whose blood pressure remains uncontrolled despite lifestyle changes and multiple medications.

High blood pressure, or hypertension, affects over 1.3 billion people globally and is a leading cause of heart attacks, strokes, and kidney disease. It’s often called the “silent killer” because many people don’t realize they have it until serious health issues arise. The new uRDN treatment could help those struggling to manage their blood pressure effectively, potentially leading to better cardiovascular health and a longer, healthier life.

The Paradise uRDN system has received FDA approval and is currently available in the U.S. It has shown positive results in several independent clinical studies involving patients with mild to moderate hypertension. While the evidence is promising, it’s important to note that this treatment is still being evaluated in real-world settings to confirm its long-term effectiveness and safety.

If you or someone you know is struggling with high blood pressure, it may be worth discussing this new treatment option with a healthcare provider. Staying informed about advancements in hypertension management can empower you to make better health choices and explore all available options for maintaining healthy blood pressure levels.

Source: globenewswire.com